These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31588877)

  • 1. A stepwise approach to implementing pharmacogenetic testing in the primary care setting.
    Weitzel KW; Duong BQ; Arwood MJ; Owusu-Obeng A; Abul-Husn NS; Bernhardt BA; Decker B; Denny JC; Dietrich E; Gums J; Madden EB; Pollin TI; Wu RR; Haga SB; Horowitz CR
    Pharmacogenomics; 2019 Oct; 20(15):1103-1112. PubMed ID: 31588877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of wide-scale pharmacogenetic testing in primary care.
    Natasha Petry ; Baye J; Aifaoui A; Wilke RA; Lupu RA; Savageau J; Gapp B; Massmann A; Hahn D; Hajek C; Schultz A
    Pharmacogenomics; 2019 Aug; 20(12):903-913. PubMed ID: 31453774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.
    Weitzel KW; Cavallari LH; Lesko LJ
    Pharm Res; 2017 Aug; 34(8):1551-1555. PubMed ID: 28466392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.
    Chang WC; Tanoshima R; Ross CJD; Carleton BC
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():65-84. PubMed ID: 33006916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings.
    Cicali EJ; Weitzel KW; Elsey AR; Orlando FA; Vinson M; Mosley S; Smith DM; Davis R; Drum L; Estores D; Franciosi JP; Hagen MG; Jerkins GJ; Mercado ES; Nainaparampil J; Padron A; Rosenberg EI; Wright A; Schmidt SO; Mathews CA; Cavallari LH; Johnson JA
    Genet Med; 2019 Oct; 21(10):2264-2274. PubMed ID: 30926959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
    Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
    Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.
    Haga SB; Mills R; Moaddeb J; Allen LaPointe N; Cho A; Ginsburg GS
    Pharmacogenomics; 2017 Mar; 18(4):359-367. PubMed ID: 28244812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands.
    Bank PCD; Swen JJ; Guchelaar HJ
    BMC Med; 2019 Jun; 17(1):110. PubMed ID: 31196067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics in Italy: current landscape and future prospects.
    Floris M; Moschella A; Alcalay M; Montella A; Tirelli M; Fontana L; Idda ML; ; Guarnieri P; Capasso M; Mammì C; Nicoletti P; Miozzo M
    Hum Genomics; 2024 Jul; 18(1):78. PubMed ID: 38987819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for pharmacogenetic testing in clinical practice guidelines in the US.
    Hertz DL; Bousman CA; McLeod HL; Monte AA; Voora D; Orlando LA; Crutchley RD; Brown B; Teeple W; Rogers S; Patel JN
    Am J Health Syst Pharm; 2024 Aug; 81(16):672-683. PubMed ID: 38652504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
    Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
    Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
    Bousman C; Maruf AA; Müller DJ
    Curr Opin Psychiatry; 2019 Jan; 32(1):7-15. PubMed ID: 30299306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
    Dias MM; Sorich MJ; Rowland A; Wiese MD; McKinnon RA
    Pharm Res; 2017 Aug; 34(8):1544-1550. PubMed ID: 28236061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models.
    Hayward J; McDermott J; Qureshi N; Newman W
    Pharmacogenomics; 2021 Aug; 22(12):761-776. PubMed ID: 34467776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical Practice.
    Wiss FM; Jakober D; Lampert ML; Allemann SS
    Genes (Basel); 2024 Jul; 15(7):. PubMed ID: 39062642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
    Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
    Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
    [No Abstract]   [Full Text] [Related]  

  • 19. Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome.
    Roden DM; Van Driest SL; Mosley JD; Wells QS; Robinson JR; Denny JC; Peterson JF
    Clin Pharmacol Ther; 2018 May; 103(5):787-794. PubMed ID: 29377064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing precision medicine in healthcare: addressing implementation challenges to increase pharmacogenetic testing in the clinical setting.
    Dong OM; Wiltshire T
    Physiol Genomics; 2017 Jul; 49(7):346-354. PubMed ID: 28550089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.